Northern Trust Corp Buys 28,520 Shares of Aetna Inc (AET)

Share on StockTwits

Northern Trust Corp lifted its stake in Aetna Inc (NYSE:AET) by 0.8% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,803,810 shares of the company’s stock after acquiring an additional 28,520 shares during the quarter. Northern Trust Corp’s holdings in Aetna were worth $697,999,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in AET. Rockefeller Capital Management L.P. acquired a new stake in shares of Aetna in the first quarter valued at about $578,000. Gabelli Funds LLC increased its position in shares of Aetna by 228.3% in the first quarter. Gabelli Funds LLC now owns 162,500 shares of the company’s stock valued at $27,463,000 after acquiring an additional 113,000 shares during the last quarter. Gamco Investors INC. ET AL acquired a new stake in shares of Aetna in the first quarter valued at about $4,750,000. Lido Advisors LLC increased its position in shares of Aetna by 16.8% in the first quarter. Lido Advisors LLC now owns 3,688 shares of the company’s stock valued at $623,000 after acquiring an additional 531 shares during the last quarter. Finally, Toronto Dominion Bank increased its position in shares of Aetna by 76.4% in the first quarter. Toronto Dominion Bank now owns 176,180 shares of the company’s stock valued at $29,767,000 after acquiring an additional 76,280 shares during the last quarter. 83.45% of the stock is currently owned by institutional investors and hedge funds.

AET has been the topic of a number of recent research reports. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $202.00 target price on shares of Aetna in a research report on Thursday, August 2nd. ValuEngine raised Aetna from a “hold” rating to a “buy” rating in a research report on Tuesday, June 26th. Finally, Zacks Investment Research raised Aetna from a “sell” rating to a “hold” rating in a research report on Monday, August 6th. Eight analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $200.38.

Shares of NYSE AET opened at $205.20 on Friday. The company has a market cap of $67.34 billion, a price-to-earnings ratio of 20.81, a price-to-earnings-growth ratio of 1.76 and a beta of 0.68. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.74 and a current ratio of 0.74. Aetna Inc has a twelve month low of $149.69 and a twelve month high of $206.66.

Aetna (NYSE:AET) last announced its quarterly earnings results on Thursday, August 2nd. The company reported $3.43 earnings per share for the quarter, topping analysts’ consensus estimates of $3.04 by $0.39. The firm had revenue of $15.56 billion for the quarter, compared to the consensus estimate of $15.59 billion. Aetna had a return on equity of 20.66% and a net margin of 5.77%. The business’s revenue was up .2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $3.42 earnings per share. analysts anticipate that Aetna Inc will post 11.31 earnings per share for the current fiscal year.

Aetna Company Profile

Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.

Further Reading: What Factors Can Affect Return on Equity?

Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply